Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Acta Dermato-Venereologica
|
September 14, 2021
Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic Dermatitis
Silvia Mariel Ferrucci, Simona Tavecchio, Luisa Angileri, et al.
Journal of Clinical Medicine
|
August 23, 2020
Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients
Simona Tavecchio, Luisa Angileri, Francesco Pozzo Giuffrida, et al.
Journal of Clinical Medicine
|
April 13, 2024
Which Factors Are Associated with Persistence of Depressive and Anxiety Symptoms in Patients Affected by Atopic Dermatitis despite 2-Year Treatment with Dupilumab?
Silvia Mariel Ferrucci, Simona Tavecchio, Alessandro Ceresa, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 23, 2024
Assessment of Patient-Reported Outcomes at 48 Months of Treatment with Dupilumab for Severe Atopic Dermatitis: A Single-Center Real-Life Experience with 126 Patients
Francesca Barei, Martina Zussino, Simona Tavecchio, et al.
Journal of Clinical Medicine
|
March 19, 2020
Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience
Silvia Ferrucci, Giovanni Casazza, Luisa Angileri, et al.
Frontiers in Allergy
|
September 27, 2023
Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
Marco Dubini, Valentina Benzecry, Federica Rivolta, et al.
Dermatology (Basel, Switzerland)
|
May 5, 2011
Cutaneous T-cell/histiocyte-rich B-cell lymphoma: a case report and review of the literature
Pamela Vezzoli, Roberta Fiorani, Valentina Girgenti, et al.
The Journal of Dermatological Treatment
|
March 9, 2022
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease
Silvia Ferrucci, Luisa Angileri, Simona Tavecchio, et al.
Therapeutic Advances in Chronic Disease
|
December 13, 2021
Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis
Silvia Ferrucci, Maurizio Romagnuolo, Carlo Alberto Maronese, et al.
The Journal of Dermatological Treatment
|
October 13, 2024
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
Francesca Barei, Paolo Calzari, Luca Valtellini, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Acta Dermato-Venereologica
|
September 14, 2021
Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic Dermatitis
Silvia Mariel Ferrucci, Simona Tavecchio, Luisa Angileri, et al.
Journal of Clinical Medicine
|
August 23, 2020
Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients
Simona Tavecchio, Luisa Angileri, Francesco Pozzo Giuffrida, et al.
Journal of Clinical Medicine
|
April 13, 2024
Which Factors Are Associated with Persistence of Depressive and Anxiety Symptoms in Patients Affected by Atopic Dermatitis despite 2-Year Treatment with Dupilumab?
Silvia Mariel Ferrucci, Simona Tavecchio, Alessandro Ceresa, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 23, 2024
Assessment of Patient-Reported Outcomes at 48 Months of Treatment with Dupilumab for Severe Atopic Dermatitis: A Single-Center Real-Life Experience with 126 Patients
Francesca Barei, Martina Zussino, Simona Tavecchio, et al.
Journal of Clinical Medicine
|
March 19, 2020
Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience
Silvia Ferrucci, Giovanni Casazza, Luisa Angileri, et al.
Frontiers in Allergy
|
September 27, 2023
Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
Marco Dubini, Valentina Benzecry, Federica Rivolta, et al.
Dermatology (Basel, Switzerland)
|
May 5, 2011
Cutaneous T-cell/histiocyte-rich B-cell lymphoma: a case report and review of the literature
Pamela Vezzoli, Roberta Fiorani, Valentina Girgenti, et al.
The Journal of Dermatological Treatment
|
March 9, 2022
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease
Silvia Ferrucci, Luisa Angileri, Simona Tavecchio, et al.
Therapeutic Advances in Chronic Disease
|
December 13, 2021
Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis
Silvia Ferrucci, Maurizio Romagnuolo, Carlo Alberto Maronese, et al.
The Journal of Dermatological Treatment
|
October 13, 2024
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
Francesca Barei, Paolo Calzari, Luca Valtellini, et al.
Page
of 3